ZymoGenetics Collects $120M in First Biotech IPO of 2002 | GenomeWeb

NEW YORK, Feb. 1 - ZymoGenetics has earned $120 million in an IPO that also marks the first initial public offering for a biotech company this year, the company said on Friday. 


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.